期刊文献+

卡贝缩宫素治疗宫缩乏力性产后出血60例临床观察 被引量:36

原文传递
导出
摘要 目的:观察卡贝缩宫素预防性治疗宫缩乏力性产后出血60例的效果。方法:选择120例剖宫产产妇,随机分为治疗组和对照组各60例。两组产妇统一采用下腹横切口长约12~15cm,刺破羊膜囊,吸净前羊水,娩出胎儿,将后羊水吸净,用子宫钳钳夹子宫切缘,并记录所吸羊水量,用吸收线连续缝合子宫肌全层,连续缝合膀胱腹膜反折,逐层关腹。对照组采用米索前列醇治疗,于胎儿娩出后给予米索前列醇400Pg口服,同时给催产素20u子宫肌注射。治疗组在对照组治疗的基础上,在胎儿分娩后,对患者直接静脉注射卡贝缩宫素100μg。结果:治疗组和对照组分别为98.3%和88.3%,治疗组总有效率和显效率均优于对照组,差异均有统计学意义;2h及24h出血量比较,治疗组均优于对照组(P〈0.05)。治疗组治疗后收缩压和舒张压分别为(109.7±11.3)mmHg、(75.1±9.7)mmHg,对照组治疗后分别为(111.2±13.8)mmHg、(76.2±9.8)mmHg。两组血压治疗前后及组间比较,差异均无统计学意义(P〉0.05),但HB下降值比较,差异有统计学意义(P〈0.05)。且两组均无明显不良反应。结论:预防性使用卡贝缩宫素可明显加强子宫收缩,对减少产后出血、降低HB值等指标具有重大意义,且卡贝缩宫素治疗宫缩乏力性产后出血也并无明显不良反应,值得临床推广使用。
作者 彭燕
出处 《中国妇幼保健》 CAS 北大核心 2014年第7期1120-1121,共2页 Maternal and Child Health Care of China
  • 相关文献

参考文献4

二级参考文献19

  • 1滕莉荣,边旭明,翟桂荣,王欣,陈倩,章小维.选择性剖宫产术后出血的药物控制研究[J].生殖医学杂志,2007,16(2):73-76. 被引量:17
  • 2再泽毅制主编.中华妇产科学[M].北京:人民卫生出版社,1999:180-183.
  • 3Arias, Femando. Pharmacology of oxytocin and prostaglandin[J]. Clin Obstet & Gynecol, 2000, 43 (3) : 455.
  • 4潘学田主编.中国进修药物手册[M].北京:北京科学技术出版社,2001:229-230.
  • 5徐玲,陈新宇,谭志红.卡贝缩宫素预防和治疗产后出血的疗效[J].实用医学杂志,2007,23(18):2940-2941. 被引量:27
  • 6曹泽毅.中华妇产科学[M].北京:人民卫生出版社,1999.2129.
  • 7WHO.Reduction of maternal mortality[R].Geneva:WHO/UNFPA/UNICEF/World Bank.1999.13.
  • 8Stones RW,Paterson CM,Saunders NJ,et al.Risk factors for major obstetric haemorrhage[J].Eur J Obstet Gynecol Reprod Biol,1993,48(1):15-18.
  • 9Combs CA,Mruphy EL,Laros RK Jr,et al.Factors associated with postpartum hemorrhage with vaginal birth[J].Obstet Gynecol,1991,77(1):69-76.
  • 10Dansereau J,Joshi AK,Helewa ME,et al.Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section[J].Am J Obstet Gynecol,1999,180(3):670-676.

共引文献458

同被引文献237

  • 1林桂珊,张兰珍.卡贝缩宫素防治高危妊娠产后出血的效果及对凝血相关因子水平影响[J].湖南师范大学学报(医学版),2020,17(2):49-52. 被引量:18
  • 2朱广玲,朱秋玲,姜萍.卡贝缩宫素预防产后出血疗效分析[J].临床研究,2014,22(8):71-72. 被引量:2
  • 3徐玲,陈新宇,谭志红.卡贝缩宫素预防和治疗产后出血的疗效[J].实用医学杂志,2007,23(18):2940-2941. 被引量:27
  • 4Rany H,Sherif H,Zidan MSA,et al.Intraumbilical injection of three different uterotonics in the management of retained placenta[J].J Obstet Gynaecol Res,2011,37(9):1203-1207.
  • 5Attilackos G,Psaroudakis D,Ash J,et al.Carbetocin versus oxytocin for the prevention of postpartum hemorrhage following cesarean section:the results of a double-blinded randomized trial[J].BJOG,2010,117(8):929-936.
  • 6Brzozowska M, Lisiecki D, Kowalska - Koprek U, et al. Comparison of carbetocin and oxytocin effectiveness for pre- vention of postpartum hemorrhage after caesarean delivery. Ginekologia polska, 2015, 86:107- 112.
  • 7Attilakos G, Psaroudakis D, Ash J, et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage fol- lowing caesarean section: the results of a double - blind ran- domisedtrial. BJOG, 2010, 117: 929 - 936.
  • 8Dagdeviren H, Cengiz H, Heydarova U, et al. Intramuscular versus intravenous prophylactic oxytocin for postpartum hemor- rhage after vaginal delivery: a randomized controlled study[J/ OL]. Arch Gynecol Obstet, 201612016-5-1]. http//www, ncbi. nlm. nih. gov/pubmed/? term = Intramuscular + versus + intrave nous + prophylactic + oxytocin + for + postpartum + hemorrhage + after + vaginal + delivery% 3A + a + randomized + controlled + study.
  • 9Yildirim D, Ozyurek SE, Ekiz A,et al. Comparison of active vs. expectant management of the third stage of labor in women with low risk of postpartum hemorrhage: a randomized controlled trial [J]. Ginekol Pol, 2016,87(5) :399-404.
  • 10Tan J, Cao Q, He GL,et al. Misoprostol versus ergometrine-ox- ytocin for preventing postpartum hemorrhage: a systematic re- view and meta-analysis of randomized controlled trials[J/OL]. J Evid Based Med, 201612016 5-l]. http://www, ncbi. him. nih. gov/pubmed/? term = Misoprostol + versus + ergometrineoxyto- cin + for + preventing + postpartum + hemorrhage 3A + a + sys- tematic + review + and + meta-analysis + of + randomized + con- trolled + trials.

引证文献36

二级引证文献312

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部